Literature DB >> 16672444

High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study.

François Trueba, Eliane Garrabe, Rachid Hadef, Roland Fabre, Jean-Didier Cavallo, Krassimira Tsvetkova, Olivier Chesneau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16672444      PMCID： PMC1479201          DOI： 10.1128/JCM.44.5.1922-1923.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  9 in total

1.  In vitro activity of quinupristin/dalfopristin, linezolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci.

Authors:  M A John; C Pletch; Z Hussain
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

2.  Rapid increase in numbers of Staphylococcus epidermidis strains with reduced susceptibility to teicoplanin in Greece.

Authors:  M Maniati; E Petinaki; A N Maniatis; I Spiliopoulou; D Petropoulou-Mylona; H Malamou-Lada; L Spaliara; Ch Koutsia-Carouzou
Journal:  Int J Antimicrob Agents       Date:  2005-04       Impact factor: 5.283

Review 3.  Pathogenesis of infections due to coagulase-negative staphylococci.

Authors:  Christof von Eiff; Georg Peters; Christine Heilmann
Journal:  Lancet Infect Dis       Date:  2002-11       Impact factor: 25.071

4.  Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study.

Authors:  E Tacconelli; M Tumbarello; K G Donati; M Bettio; T Spanu; F Leone; L A Sechi; S Zanetti; G Fadda; R Cauda
Journal:  Clin Infect Dis       Date:  2001-10-05       Impact factor: 9.079

5.  Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.

Authors:  L Del' Alamo; R F Cereda; I Tosin; E A Miranda; H S Sader
Journal:  Diagn Microbiol Infect Dis       Date:  1999-07       Impact factor: 2.803

6.  Bacteraemia caused by coagulase-negative staphylococci exhibiting decreased susceptibility to teicoplanin.

Authors:  S Lallemand; M Thouverez; K Boisson; D Talon; X Bertrand
Journal:  J Hosp Infect       Date:  2002-07       Impact factor: 3.926

7.  Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.

Authors:  G L Cartolano; M Cheron; D Benabid; M Leneveu; A Boisivon
Journal:  Clin Microbiol Infect       Date:  2004-05       Impact factor: 8.067

8.  Characteristics of French methicillin-resistant Staphylococcus aureus isolates with decreased susceptibility or resistance to glycopeptides.

Authors:  Névine El Solh; Marilyne Davi; Anne Morvan; Hélène Aubry Damon; Nicole Marty
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

9.  Infection in total joint replacements. Why we screen MRSA when MRSE is the problem?

Authors:  S S Mohanty; P R Kay
Journal:  J Bone Joint Surg Br       Date:  2004-03
  9 in total
  10 in total

1.  Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function.

Authors:  Zsolt Szűcs; Magdolna Csávás; Erzsébet Rőth; Anikó Borbás; Gyula Batta; Florent Perret; Eszter Ostorházi; Réka Szatmári; Evelien Vanderlinden; Lieve Naesens; Pál Herczegh
Journal:  J Antibiot (Tokyo)       Date:  2016-06-29       Impact factor: 2.649

2.  Genetic analysis of glycopeptide-resistant Staphylococcus epidermidis strains from bone and joint infections.

Authors:  Julie Cremniter; Valérie Sivadon-Tardy; Charlotte Caulliez; Thomas Bauer; Raphaël Porcher; Alain Lortat-Jacob; Philippe Piriou; Thierry Judet; Philippe Aegerter; Jean-Louis Herrmann; Jean-Louis Gaillard; Martin Rottman
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

3.  Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades.

Authors:  E Ahlstrand; K Svensson; L Persson; U Tidefelt; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-05       Impact factor: 3.267

Review 4.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections.

Authors:  Julie Cremniter; Asma Slassi; Jean-Charles Quincampoix; Valérie Sivadon-Tardy; Thomas Bauer; Raphaël Porcher; Alain Lortat-Jacob; Philippe Piriou; Thierry Judet; Jean-Louis Herrmann; Jean-Louis Gaillard; Martin Rottman
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

6.  Prevalence of antibiotic resistance in multi-drug resistant coagulase-negative staphylococci isolated from invasive infection in very low birth weight neonates in two Polish NICUs.

Authors:  Monika Brzychczy-Wloch; Maria Borszewska-Kornacka; Ewa Gulczynska; Jadwiga Wojkowska-Mach; Malgorzata Sulik; Monika Grzebyk; Malgorzata Luchter; Piotr B Heczko; Malgorzata Bulanda
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-12-20       Impact factor: 3.944

7.  Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.

Authors:  Koichi Yamada; Hiroki Namikawa; Hiroki Fujimoto; Kiyotaka Nakaie; Etsuko Takizawa; Yasuyo Okada; Akiko Fujita; Hiroyoshi Kawaguchi; Yasutaka Nakamura; Junko Abe; Yukihiro Kaneko; Hiroshi Kakeya
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

Review 8.  Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.

Authors:  Sameer Dhingra; Nor Azlina A Rahman; Ed Peile; Motiur Rahman; Massimo Sartelli; Mohamed Azmi Hassali; Tariqul Islam; Salequl Islam; Mainul Haque
Journal:  Front Public Health       Date:  2020-11-04

9.  Vancomycin intermediate resistant Staphylococcus aureus in the nasal cavity of asymptomatic individuals: a potential public health challenge.

Authors:  Morenike Adeoye-Isijola; Olufunmiso Olajuyigbe; Kehinde Adebola; Roger Coopoosamy; Anthony Afolayan
Journal:  Afr Health Sci       Date:  2020-09       Impact factor: 0.927

10.  Comparison of teicoplanin disk diffusion and broth microdilution methods against clinical isolates of Staphylococcus aureus and S. epidermidis.

Authors:  Carlos Henrique Camargo; Alessandro Lia Mondelli; Paulo José Fortes Villas Bôas
Journal:  Braz J Microbiol       Date:  2011-12-01       Impact factor: 2.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.